Literature DB >> 8340159

Renal nitric oxide and angiotensin II interaction in renovascular hypertension.

D H Sigmon1, W H Beierwaltes.   

Abstract

In two-kidney, one clip (2K1C) renovascular hypertension, blood flow is reduced to the clipped but not to the nonclipped kidney, despite elevated angiotensin II. To determine possible interactions between endothelium-derived nitric oxide and angiotensin, we studied bilateral renal blood flow using radioactive microspheres in anesthetized 2K1C hypertensive rats 4 weeks after clipping. We studied the response to nitric oxide synthesis inhibition with 10 mg/kg body wt NG-nitro-L-arginine- methyl ester (L-NAME) in hypertensive rats untreated (n = 5) or treated (n = 5) with 10 mg/kg body wt of the angiotensin II antagonist losartan. 2K1C rats had a blood pressure of 159 +/- 9 mm Hg, and renal blood flow to the clipped kidney was reduced 87% compared with the nonclipped kidney. L-NAME increased blood pressure 36 +/- 5 mm Hg and decreased renal blood flow in the nonclipped kidney 61% (4.9 +/- 0.5 to 1.9 +/- 0.4 mL/min per gram kidney weight, P < .001). Renal vascular resistance increased 200% (33.4 +/- 2.2 to 100.7 +/- 15.0 resistance units [RU], P < .005). Renal blood flow and resistance in the clipped kidney were unchanged by L-NAME. Treatment of 2K1C rats with losartan reduced blood pressure (154 +/- 8 to 116 +/- 11 mm Hg, P < .01), did not change blood flow in the nonclipped, but normalized it in the clipped kidney (4.8 +/- 0.8 mL/min per gram kidney weight).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340159     DOI: 10.1161/01.hyp.22.2.237

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Smooth muscle contractile diversity in the control of regional circulations.

Authors:  John J Reho; Xiaoxu Zheng; Steven A Fisher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-01       Impact factor: 4.733

2.  Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat.

Authors:  S L Cox; D F Story; J Ziogas
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Increased activity and expression of Ca(2+)-dependent NOS in renal cortex of ANG II-infused hypertensive rats.

Authors:  S Y Chin; K N Pandey; S J Shi; H Kobori; C Moreno; L G Navar
Journal:  Am J Physiol       Date:  1999-11

Review 4.  Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms.

Authors:  Dewan S A Majid; Minolfa C Prieto; Luis Gabriel Navar
Journal:  Curr Hypertens Rev       Date:  2015

5.  Resveratrol induces acute endothelium-dependent renal vasodilation mediated through nitric oxide and reactive oxygen species scavenging.

Authors:  Kevin L Gordish; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-15

6.  Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.

Authors:  Šárka Jíchová; Libor Kopkan; Zuzana Husková; Šárka Doleželová; Jan Neckář; Petr Kujal; Zdenka Vernerová; Herbert J Kramer; Janusz Sadowski; Elzbieta Kompanowska-Jezierska; Rami N Reddy; John R Falck; John D Imig; Luděk Červenka
Journal:  J Hypertens       Date:  2016-10       Impact factor: 4.844

7.  Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production.

Authors:  Tanya M Gwathmey; Hossam A Shaltout; Karl D Pendergrass; Nancy T Pirro; Jorge P Figueroa; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-25

8.  Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.

Authors:  Libor Kopkan; Zuzana Husková; Alexandra Sporková; Šárka Varcabová; Zuzana Honetschlägerová; Sung Hee Hwang; Hsing-Ju Tsai; Bruce D Hammock; John D Imig; Herbert J Kramer; Marcela Bürgelová; Alžběta Vojtíšková; Petr Kujal; Zdenka Vernerová; Luděk Červenka
Journal:  Kidney Blood Press Res       Date:  2012-08-29       Impact factor: 2.687

Review 9.  Endovascular versus medical therapy for atherosclerotic renovascular disease.

Authors:  Mark Shipeng Yu; David A Folt; Christopher A Drummond; Steven T Haller; Emily L Cooper; Pamela Brewster; Kaleigh L Evans; Christopher J Cooper
Journal:  Curr Atheroscler Rep       Date:  2014-12       Impact factor: 5.113

10.  Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice.

Authors:  Ludek Cervenka; Ivana Vanecková; Zuzana Husková; Zdenka Vanourková; Michaela Erbanová; Monika Thumová; Petra Skaroupková; Martin Opocenský; Jan Malý; Vera Certíková Chábová; Vladimír Tesar; Marcela Bürgelová; Ondrej Viklický; Vladimír Teplan; Michal Zelízko; Herbert J Kramer; L Gabriel Navar
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.